Ibrutinib dose intensity in high-risk chronic lymphocytic leukemia.
Hematol Oncol
; 40(5): 1100-1104, 2022 12.
Article
in En
| MEDLINE
| ID: mdl-35613703
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Leukemia, Lymphocytic, Chronic, B-Cell
Type of study:
Etiology_studies
/
Risk_factors_studies
Limits:
Humans
Language:
En
Journal:
Hematol Oncol
Year:
2022
Document type:
Article
Affiliation country:
Switzerland
Country of publication:
United kingdom